TW273516B - Adhesive matrix-type transdermal therapeutic set for motion sickness - Google Patents
Adhesive matrix-type transdermal therapeutic set for motion sicknessInfo
- Publication number
- TW273516B TW273516B TW83100442A TW83100442A TW273516B TW 273516 B TW273516 B TW 273516B TW 83100442 A TW83100442 A TW 83100442A TW 83100442 A TW83100442 A TW 83100442A TW 273516 B TW273516 B TW 273516B
- Authority
- TW
- Taiwan
- Prior art keywords
- drug
- matrix
- adhesive layer
- present
- scopolamine
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The present invention is to an adhesive matrix-type transdermal therapeutic set for motion sickness. The present set includes a backing layer, a drug-matrix adhesive layer, and a release liner. The drug-matrix adhesive layer is prepared by dissolving or dispersing scopolamine in pressure-sensitive adhesives or in a polymer matrix coated with pressure-sensitive adhesives. When the set is administered to the patient, the release liner is removed from the system prior to the application and the drug-matrix adhesive layer is in direct contacting with the skin surface. Hence, the scopolamine is released from the drug-matrix adhesive layer and systemically absorbed through the skin. No rate-controlling membrane is utilized in the present set to control the drug release rate, and therefore, the manufacture process will be more simple and cost less as compared to the reservoir-type one. In addition, the present invention provides a convenient and safe method for the administration of scopolamine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW83100442A TW273516B (en) | 1994-01-19 | 1994-01-19 | Adhesive matrix-type transdermal therapeutic set for motion sickness |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW83100442A TW273516B (en) | 1994-01-19 | 1994-01-19 | Adhesive matrix-type transdermal therapeutic set for motion sickness |
Publications (1)
Publication Number | Publication Date |
---|---|
TW273516B true TW273516B (en) | 1996-04-01 |
Family
ID=51397153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW83100442A TW273516B (en) | 1994-01-19 | 1994-01-19 | Adhesive matrix-type transdermal therapeutic set for motion sickness |
Country Status (1)
Country | Link |
---|---|
TW (1) | TW273516B (en) |
-
1994
- 1994-01-19 TW TW83100442A patent/TW273516B/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4655768A (en) | Bandage for sustained delivery of drugs | |
UA18868A (en) | Transdermal therapeutic system | |
AU679032B2 (en) | Transdermal therapeutic system with galanthamine as active ingredient | |
WO2000033812A3 (en) | Transdermal patch for delivering volatile liquid drugs | |
AU622775B2 (en) | A plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release, process for the production of the plaster and the use thereof | |
CA2064687A1 (en) | Method and device for administering dexmedetomidine transdermaly | |
ATE5563T1 (en) | THERAPEUTIC SYSTEM FOR DELIVERING MEDICATIONS TO THE SKIN. | |
FI960556A0 (en) | Transdermal slow flow delivery system for active drugs | |
NZ235068A (en) | Transdermal drug delivery system with the drug dispersed in a pressure sensitive adhesive acrylate polymer | |
JP2002531488A5 (en) | ||
GB9111732D0 (en) | The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs | |
ES8704740A1 (en) | Controlled-release drugsystem and process for preparing it. | |
CA2010225A1 (en) | Therapeutic System for the Retarded and Controlled Transdermal or Transmucous Administration of Active Substances (1) | |
WO1994025025A3 (en) | Systems for controlled release of pilocarpine | |
AU2001230193A1 (en) | Transdermal therapeutic system for the administration of zaleplon | |
TW273516B (en) | Adhesive matrix-type transdermal therapeutic set for motion sickness | |
AU9343498A (en) | Transdermal therapeutic system comprising the active substance scopolamine base | |
MY110391A (en) | Nitroglycerin-containing patch, a process for the production and the use thereof | |
AU584025B2 (en) | Bandage for sustained delivery of drugs | |
AU684256B2 (en) | Transdermal therapeutic system for administering physostigmin through the skin, and a method of producing the system | |
JPS62230720A (en) | Laminated pharmaceutical | |
WO1991018572A1 (en) | Device for transdermal administration of drugs | |
Hogan et al. | Transdermal drug delivery systems: An academic view. |